We studied the clinical manifestations of Bancroftian filariasis in relation to microfilaraemia and diethylcarbamazine (DEC) therapy in three groups of individuals in Pondicherry. In 3170 persons examined in a door-to-door survey (Group I), the prevalence of disease was found to be independent of microfilaria (mf) status (the disease rate was 13.4% in mf carriers and 13.6% in amicrofilaraemic persons). There was no association between the occurrence of disease (and individual manifestations), and mf status and its intensity in 1103 mf carriers examined in the filariasis clinic (Group II). Clinical manifestations, however, were age and sex dependent in Group II. Change in mf status in a five-year period (1981 to 1986) with and without DEC therapy did not influence the clinical manifestations in 1024 individuals (Group III). Though the disease rate in mf carriers who discontinued DEC (22.2%) and in those who completed one course of DEC (14.8%) was higher than those who did not receive DEC (10.6%), statistical analysis did not show any significant difference between the groups. The study confirms that the dynamics of infection and filarial disease are complex, and other associated factors need to be investigated.

Download full-text PDF

Source

Publication Analysis

Top Keywords

clinical manifestations
16
manifestations bancroftian
8
bancroftian filariasis
8
filariasis relation
8
relation microfilaraemia
8
microfilaraemia diethylcarbamazine
8
dec therapy
8
disease rate
8
dec
5
disease
5

Similar Publications

Background: Mycoplasma pneumoniae is a prevalent pathogen in pediatric community-acquired pneumonia. Currently, limited literature exists on the clinical utilization of pathogen-targeted sequencing technologies.

Methods: Targeted next-generation sequencing (tNGS) technology was employed to analyze bronchoalveolar lavage fluid (BALF) from 1,070 hospitalized pediatric patients with acute lower respiratory tract infections.

View Article and Find Full Text PDF

Chronic graft-versus-host disease (cGVHD) is a major serious complication after allogeneic stem-cell transplantation (allo-HSCT), and often mimics autoimmune diseases. Central nervous system (CNS) symptoms are rare manifestations of cGVHD, and are difficult to diagnose. CNS manifestations of cGVHD were discussed in the 2020 National Institutes of Health cGVHD Consensus Project as one of the "atypical cGVHD manifestations" with involvement of various organ systems other than classical cGVHD organs.

View Article and Find Full Text PDF

Developmental functional brain network abnormalities in autism spectrum disorder comorbid with attention deficit hyperactivity disorder.

Eur J Pediatr

January 2025

Department of Developmental and Behavioral Pediatrics, Children's Medical Center, The First Hospital of Jilin University, Jilin University, Changchun, China.

Unlabelled: Autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) often co-occur. Developmental stages significantly influence the variations in brain alterations. However, whether ASD comorbid with ADHD (ASD + ADHD) represents a unique neural characteristic from ASD without comorbid ADHD (ASD-alone), or instead manifests a shared neural correlate associated with ASD across diverse age cohorts remain unclear.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic has exacerbated already existing stressors within health care. In August 2020, a campus-wide COVID-19 well-being survey indicated high levels of burnout, stress, and mental health concerns among certified nurse practitioners (CNPs), clinical nurse specialists (CNSs), and physician assistants (PAs) within our Department of Medicine.

Purpose: In response to this survey, an interdisciplinary task force was formed by CNPs, CNSs, and PAs across departmental specialty divisions to conduct focus groups to gain a deeper understanding of workplace experience both prepandemic and during the COVID-19 pandemic.

View Article and Find Full Text PDF

Background: Patients with post-COVID condition (PCC) and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) experience symptoms potentially associated with small fiber neuropathy (SFN).

Methods: A sample of 90 participants, comprising 30 PCC patients, 30 ME/CFS patients, and 30 healthy controls (HC), matched by sex and age, was assessed. Neuropathic, autonomic, and fatigue symptoms were measured with TaskForce Monitor, the Sudoscan, heat and cold evoked potentials, In Vivo Corneal Confocal Microscopy (IVCCM), and specialized questionaries.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!